References
- Porru M, Pompili L, Caruso C, Biroccio A, Leonetti C. Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities. J Exp Clin Cancer Res CR. 2018;37(1):57. doi:10.1186/s13046-018-0719-129534749
- Artale S, Sartore-Bianchi A, Veronese SM, et al. Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(25):4217–4219. doi:10.1200/JCO.2008.18.7286
- Santini D, Loupakis F, Vincenzi B, et al. High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice. Oncologist. 2008;13(12):1270–1275. doi:10.1634/theoncologist.2008-018119056857
- Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319(9):525–532. doi:10.1056/NEJM1988090131909012841597
- Huang D, Sun W, Zhou Y, et al. Mutations of key driver genes in colorectal cancer progression and metastasis. Cancer Metastasis Rev. 2018;37(1):173–187. doi:10.1007/s10555-017-9726-529322354
- Lièvre A, Bachet J-B, Boige V, et al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(3):374–379. doi:10.1200/JCO.2007.12.5906
- Amado RG, Wolf M, Peeters M, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(10):1626–1634. doi:10.1200/JCO.2007.14.7116
- Douillard J-Y, Oliner KS, Siena S, et al. Panitumumab – FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med. 2013;369(11):1023–1034. doi:10.1056/NEJMoa130527524024839
- Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386–1422. doi:10.1093/annonc/mdw14127380959
- Phua LC, Ng HW, Yeo AHL, et al. Prevalence of KRAS, BRAF, PI3K and EGFR mutations among Asian patients with metastatic colorectal cancer. Oncol Lett. 2015;Oct;10(4):2519–2526. doi:10.3892/ol.2015.3560
- Ciardiello F, Tejpar S, Normanno N, et al. Uptake of KRAS mutation testing in patients with metastatic colorectal cancer in Europe, Latin America and Asia. Target Oncol. 2011;6(3):133–145. doi:10.1007/s11523-011-0181-x21630045
- Chretien A-S, Harlé A, Meyer-Lefebvre M, et al. Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer. Cancer Med. 2013;Feb(1):11–20. doi:10.1002/cam4.47
- Les cancers en France, édition 2017, collection Les Données. Avril: institut national du cancer; 2018.
- Pornet C, Delpierre C, Dejardin O, et al. Construction of an adaptable European transnational ecological deprivation index: the French version. J Epidemiol Community Health. 2012;66(11):982–989. doi:10.1136/jech.2010.10953822544918
- Besag J, York J, Mollié A. Bayesian image restoration, with two applications in spatial statistics. Ann Inst Stat Math. 1991;43(1):1–20. doi:10.1007/BF00116466
- Bernardinelli L, Clayton D, Montomoli C. Bayesian estimates of disease maps: how important are priors? Stat Med. 1995;14(21–22):2411–2431. doi:10.1002/sim.47801421118711278
- Blangiardo M, Cameletti M, Baio G, Rue H. Spatial and spatio-temporal models with R-INLA. Spat Spatio-Temporal Epidemiol. 2013;1(4):33–49. doi:10.1016/j.sste.2012.12.001
- Kulldorff M. A spatial scan statistic. Commun Stat – Theory Methods. 1997;26(6):1481–1496. doi:10.1080/03610929708831995
- Genin M, Duhamel A, Preda C, et al. Space-time clusters of Crohn’s disease in northern France. J Public Health. 2013;21(6):497–504. doi:10.1007/s10389-013-0580-9
- Beuscart J-B, Genin M, Dupont C, et al. Potentially inappropriate medication prescribing is associated with socioeconomic factors: a spatial analysis in the French Nord-Pas-de-Calais Region. Age Ageing. 2017. doi:10.1093/ageing/afw245
- Cucala L, Genin M, Lanier C, Occelli F. A multivariate Gaussian scan statistic forspatial data. Spat Stat. 2017;1(21):66–74. doi:10.1016/j.spasta.2017.06.001
- Castra L, Genin M, Escutnaire J, et al. Socioeconomic status and incidence of cardiac arrest: a spatial approach to social and territorial disparities. Eur J Emerg Med. 2019Jun;26(3):180–187.
- Kulldorff M, Huang L, Pickle L, Duczmal L. An elliptic spatial scan statistic. Stat Med. 2006;25(22):3929–3943. doi:10.1002/sim.249016435334
- Lawson A. Bayesian Disease Mapping: Hierarchical Modeling in Spatial Epidemiology. Third ed. Boca Raton, Florida: CRC Press; 2018.
- R Core Team. R: A Language and Environment for Statistical Computing. [internet]. Vienna, Austria: R Foundation for Statistical Computing; 2016 Available from: https://www.R-project.org/. Accessed 81, 2019.
- Kulldorff M. SaTScan: software for the spatial and space-time scan statistics. Available from: http://www.satscan.org/. Accessed 81, 2019.
- QGIS Development Team. QGIS Geographic Information System. Open Source Geospatial Foundation Project; 2018 Available from: http://qgis.osgeo.org. Accessed 81, 2019.
- Patil H, Korde R, Kapat A. KRAS gene mutations in correlation with clinicopathological features of colorectal carcinomas in Indian patient cohort. Med Oncol Northwood Lond Engl. 2013;30(3):617. doi:10.1007/s12032-013-0617-5
- Gil Ferreira C, Aran V, Zalcberg-Renault I, et al. KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients. BMC Gastroenterol. 2014;14:73. doi:10.1186/1471-230X-14-7324720724
- Staudacher JJ, Yazici C, Bul V, et al. Increased frequency of KRAS mutations in African Americans compared with caucasians in sporadic colorectal cancer. Clin Transl Gastroenterol. 2017;8(10):e124. doi:10.1038/ctg.2017.4829048416
- Martínez F, Fernández-Martos C, Quintana MJ, et al. APC and KRAS mutations in distal colorectal polyps are related to smoking habits in men: results of a cross-sectional study. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex. 2011;13(9):664–671.
- Curtin K, Samowitz WS, Wolff RK, Herrick J, Caan BJ, Slattery ML. Somatic alterations, metabolizing genes and smoking in rectal cancer. Int J Cancer. 2009;125(1):158–164. doi:10.1002/ijc.v125:119358278
- Jayasekara H, MacInnis RJ, Williamson EJ, et al. Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRAF-/KRAS− but not BRAF+ colorectal cancer. Int J Cancer. 2017;140(7):1485–1493. doi:10.1002/ijc.3056827943267
- Brändstedt J, Wangefjord S, Nodin B, et al. Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women: a cohort study. PLoS One. 2014;9(6):e98964. doi:10.1371/journal.pone.009896424918610
- Réalisé au sein de l’observatoire régional de la santé et du social. Diagnostic territorialisé des hauts-de-france territoires de proximité. https://www.hauts-de-france.ars.sante.fr/sites/default/files/2017-01/ORS-Diagnostic_part_1_0.pdf. Accessed 81, 2019.
- Colonna M, Mitton N, Remontet L, et al. Incidence régionale des cancers 2008–2010. Évaluation de trois méthodes d’estimations: Analyse et résultats. Saint-Maurice, France: Institut de veille sanitaire; 2014:191.
- López-Abente G, García-Pérez J, Fernández-Navarro P, Boldo E, Ramis R. Colorectal cancer mortality and industrial pollution in Spain. BMC Public Health. 2012;1(12):589. doi:10.1186/1471-2458-12-589
- Martin FL, Martinez EZ, Stopper H, Garcia SB, Uyemura SA, Kannen V. Increased exposure to pesticides and colon cancer: early evidence in Brazil. Chemosphere. 2018;209:623–631. doi:10.1016/j.chemosphere.2018.06.11829957523
- Kachuri L, Villeneuve PJ, Parent M-É, Johnson KC, Harris SA. Workplace exposure to diesel and gasoline engine exhausts and the risk of colorectal cancer in Canadian men. Environ Health Glob Access Sci Source. 2016;14(15):4.
- Turner MC, Krewski D, Diver WR, et al. Ambient air pollution and cancer mortality in the cancer prevention study II. Environ Health Perspect. 2017;125(8):087013. doi:10.1289/EHP3628886601